Dicamba is a benzoic acid derivative, present here as the dimethylamine salt

FARMALINX Pty Ltd

Revision date : 2009-10-01

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS07
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

7732-18-5

Name of the chemical

Water, distilled, conductivity or of similar purity H2O

Concentration

N/A

General Information

Revision date

2009-10-01

Product name

Dicamba is a benzoic acid derivative, present here as the dimethylamine salt

Product name

Dicamba is a benzoic acid derivative, present here as the dimethylamine salt

Identification on the label/Trade name

FarmaLinx Dicam Herbicide

Substance name

Dicamba is a benzoic acid derivative, present here as the dimethylamine salt

Icons in SDS

Company Information

company name

FARMALINX Pty Ltd

Section 2

Hazard statements

This product is classified as: Xn, Harmful. Xi, Irritating. Hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. R22, R36. Harmful if swallowed. Irritating to eyes

Precautionary statements

S20, S23, S36, S61, S24/25. When using, do not eat or drink. Do not breathe spray mists. Wear suitable protective clothing. Avoid release to the environment. Refer to special instructions/Safety Data Sheets. Avoid contact with skin and eyes.

SUSDP Classification

S6

ADG classification

None allocated. Not a Dangerous Good under the ADG Code

UN Number

None allocated Emergency Overview Physical Description & Colour: Clear colourless liquid. Odour: Mild but characteristic odour.

Health hazards

Symptoms of poisoning with Dicamba include loss of appetite (anorexia), vomiting, muscle weakness, slowed heart rate, shortness of breath, central nervous system effects (victim may become excited or depressed), benzoic acid in the urine, incontinence, cyanosis (bluing of the skin and gums), and exhaustion following repeated muscle spasms. In addition to these symptoms, inhalation can cause irritation of the linings of the nasal passages and the lungs, and loss of voice. This product is harmful if swallowed, eye irritant.

Potential health effects

Inhalation: Short Term Exposure: Available data indicates that this product is not harmful. However product may be mildly irritating, although unlikely to cause anything more than mild transient discomfort. Long Term Exposure: No data for health effects associated with long term inhalation. Skin Contact: Short Term Exposure: Available data indicates that this product is not harmful. It should present no hazards in normal use. However product may be irritating, but is unlikely to cause anything more than mild transient discomfort. Long Term Exposure: No data for health effects associated with long term skin exposure. Eye Contact: Short Term Exposure: This product is an eye irritant. Symptoms may include stinging and reddening of eyes and watering which may become copious. Other symptoms may also become evident. If exposure is brief, symptoms should disappear once exposure has ceased. However, lengthy exposure or delayed treatment may cause permanent damage. Long Term Exposure: No data for health effects associated with long term eye exposure. Ingestion: Short Term Exposure: Significant oral exposure is considered to be unlikely. Available data shows that this product is harmful; see symptoms above. However, this product is an oral irritant. Symptoms may include burning sensation and reddening of skin in mouth and throat. Other symptoms may also become evident, but all should disappear once exposure has ceased. Long Term Exposure: No data for health effects associated with long term ingestion. Carcinogen Status: SWA: No significant ingredient is classified as carcinogenic by SWA. NTP: No significant ingredient is classified as carcinogenic by NTP. IARC: No significant ingredient is classified as carcinogenic by IARC.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.